참고문헌
- Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999; 353: 1695-700. https://doi.org/10.1016/S0140-6736(99)01310-0
- Banning A, Sjogren P, Henriksen H. Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic. Pain 1991; 45: 45-8. https://doi.org/10.1016/0304-3959(91)90163-R
- Coleman RE, Houston S, Purohit OP, Rubens RD, Kandra A, Ford J. A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer. Eur J Cancer 1998; 34: 820-4. https://doi.org/10.1016/S0959-8049(97)10155-1
- Coleman RE. How can we improve the treatment of bone metastases further? Curr Opin Oncol 1998; 10(Suppl 1): S7-13.
- Mercadante S, Arcuri E. Breakthrough pain in cancer patients: pathophysiology and treatment. Cancer Treat Rev 1998; 24: 425-32. https://doi.org/10.1016/S0305-7372(98)90005-6
- Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain 1997; 69: 1-18. https://doi.org/10.1016/S0304-3959(96)03267-8
- Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999; 81: 129-34. https://doi.org/10.1016/S0304-3959(99)00006-8
- Mercadante S, Fulfaro F. Management of painful bone metastases. Curr Opin Oncol 2007; 19: 308-14. https://doi.org/10.1097/CCO.0b013e3281214400
- O'Connor JP, Lysz T. Celecoxib, NSAIDs and the skeleton. Drugs Today (Barc) 2008; 44: 693-709. https://doi.org/10.1358/dot.2008.44.9.1251573
- Vanderah TW, Gardell LR, Burgess SE, Ibrahim M, Dogrul A, Zhong CM, et al. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 2000; 20: 7074-9.
- Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacol 1992; 36: 27-38. https://doi.org/10.1016/0378-8741(92)90057-X
- Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999; 58: 1685-93. https://doi.org/10.1016/S0006-2952(99)00212-9
- Nah JJ, Hahn JH, Chung S, Choi S, Kim YI, Nah SY. Effect of ginsenosides, active components of ginseng, on capsaicin-induced pain-related behavior. Neuropharmacology 2000; 39: 2180-4. https://doi.org/10.1016/S0028-3908(00)00048-4
- Shin DJ, Yoon MH, Lee HG, Kim WM, Park BY, Kim YO, et al. The effect of treatment with intrathecal ginsenosides in a rat model of postoperative pain. Korean J Pain 2007; 20: 100-5. https://doi.org/10.3344/kjp.2007.20.2.100
- Kim SY, Yoon MH, Lee HG, Kim WM, Lee JD, Kim YO, et al. The role of adrenergic and cholinergic receptors on the antinociception of Korean red ginseng in the spinal cord of rats. Korean J Pain 2008; 21: 27-32. https://doi.org/10.3344/kjp.2008.21.1.27
- Schwei MJ, Honore P, Rogers SD, Salak-Johnson JL, Finke MP, Ramnaraine ML, et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci 1999; 19: 10886-97.
- Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980; 67: 313-6. https://doi.org/10.1016/0014-2999(80)90515-4
- Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980; 20: 441-62. https://doi.org/10.1146/annurev.pa.20.040180.002301
- Yoon MH, Choi JI, Jeong SW. Antinociception of intrathecal cholinesterase inhibitors and cholinergic receptors in rats. Acta Anaesthesiol Scand 2003; 47: 1079-84. https://doi.org/10.1034/j.1399-6576.2003.00212.x
- Nah SY. Ginseng; recent advances and trends. Korean J Ginseng Sci 1997; 21: 1-12.
- Kaku T, Miyata T, Uruno T, Sako I, Kinoshita A. Chemicopharmacological studies on saponins of Panax ginseng C. A. Meyer. II. Pharmacological part. Arzneimittelforschung 1975; 25: 539-47.
- Lee JH, Jeong SM, Lee BH, Kim DH, Kim JH, Kim JI, et al. Differential effect of bovine serum albumin on ginsenoside metabolite-induced inhibition of alpha3beta4 nicotinic acetylcholine receptor expressed in Xenopus oocytes. Arch Pharm Res 2003; 26: 868-73. https://doi.org/10.1007/BF02980034
- Nah SY, McCleskey EW. Ginseng root extract inhibits calcium channels in rat sensory neurons through a similar path, but different receptor, as mu-type opioids. J Ethnopharmacol 1994; 42: 45-51. https://doi.org/10.1016/0378-8741(94)90022-1
- Nah SY, Park HJ, McCleskey EW. A trace component of ginseng that inhibits Ca2+ channels through a pertussis toxin-sensitive G protein. Proc Natl Acad Sci USA 1995; 92: 8739-43. https://doi.org/10.1073/pnas.92.19.8739
- Rhim H, Kim H, Lee DY, Oh TH, Nah SY. Ginseng and ginsenoside Rg3, a newly identified active ingredient of ginseng, modulate Ca2+ channel currents in rat sensory neurons. Eur J Pharmacol 2002; 436: 151-8. https://doi.org/10.1016/S0014-2999(01)01613-2
- Shin YH, Jung OM, Nah JJ, Nam KY, Kim CY, Nah SY. Ginsenosides that produce differential antinociception in mice. Gen Pharmacol 1999; 32: 653-9. https://doi.org/10.1016/S0306-3623(98)00239-0
피인용 문헌
- Assessment and refinement of intra-bone marrow transplantation in mice vol.49, pp.2, 2015, https://doi.org/10.1177/0023677214559627
- Ginsenoside Rf relieves mechanical hypersensitivity, depression-like behavior, and inflammatory reactions in chronic constriction injury rats pp.0951418X, 2019, https://doi.org/10.1002/ptr.6303
- Antinociceptive effects of Ginsenoside Rb1 in a rat model of cancer-induced bone pain vol.17, pp.5, 2010, https://doi.org/10.3892/etm.2019.7404
- Intra-iliac bone marrow injection as a novel alternative to intra-tibial inoculation in rat model vol.12, pp.1, 2010, https://doi.org/10.1186/s13287-021-02413-7